| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LTD | Executive VP, Global R&D | Ordinary Shares | 1.39K | $13.5K | $9.73 | May 17, 2022 | Direct |
| TEVA PHARMACEUTICAL INDUSTRIES LTD | Executive VP, Global R&D | Restricted Share Units | 71.3K | Mar 5, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | May 17, 2022 | 1 | -$1.07M | 4 | May 19, 2022 | Executive VP, Global R&D |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Mar 4, 2022 | 10 | -$250K | 4 | Mar 8, 2022 | Executive VP, Global R&D |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Feb 28, 2022 | 3 | -$61.8K | 4 | Mar 2, 2022 | Executive VP, Global R&D |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Feb 8, 2022 | 4 | -$55.4K | 4 | Feb 10, 2022 | Executive VP, Global R&D |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Aug 10, 2021 | 1 | -$506K | 4 | Aug 12, 2021 | Executive VP, Global R&D |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | May 11, 2021 | 3 | -$195K | 4 | May 13, 2021 | Executive VP, Global R&D |